Suppr超能文献

将氮原子引入酰胺基烷基吲哚:具有增强水溶性的强效且选择性的大麻素2型受体激动剂。

Introducing nitrogen atoms to amidoalkylindoles: potent and selective cannabinoid type 2 receptor agonists with improved aqueous solubility.

作者信息

Ji Yue-Yang, Wang Zhi-Long, Pei Fang-Ning, Shi Jun-Jie, Li Jiao-Jiao, Gunosewoyo Hendra, Yang Fan, Tang Jie, Xie Xin, Yu Li-Fang

机构信息

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , School of Chemistry and Molecular Engineering , East China Normal University , 3663 North Zhongshan Road , Shanghai 200062 , China . Email:

CAS Key Laboratory of Receptor Research , National Center for Drug Screening , Shanghai Institute of Materia Medica , Chinese Academy of Sciences , 189 Guo Shou Jing Road , Shanghai 201203 , China . Email:

出版信息

Medchemcomm. 2019 Nov 18;10(12):2131-2139. doi: 10.1039/c9md00411d. eCollection 2019 Dec 1.

Abstract

Previously we identified a series of amidoalkylindoles as potent and selective CB partial agonists. In the present study, we report our continuous effort to improve the aqueous solubility by introducing N atoms to the amidoalkylindole framework. Synthesis, characterization, and pharmacology evaluations were described. Bioisosteric replacements of the indole nucleus with an indazole, azaindole and benzimidazole were explored. Benzimidazole (EC = NA, EC = 0.067 μM) and azaindole (EC = NA, EC = 0.048 μM) were found to be potent and selective CB receptor partial agonists, both with improved aqueous solubility.

摘要

此前我们鉴定出一系列氨基烷基吲哚为强效且选择性的CB部分激动剂。在本研究中,我们报告了我们通过在氨基烷基吲哚骨架中引入氮原子来提高水溶性的持续努力。描述了合成、表征和药理学评价。探索了用吲唑、氮杂吲哚和苯并咪唑对吲哚核进行生物电子等排体替换。发现苯并咪唑(EC = NA,EC = 0.067 μM)和氮杂吲哚(EC = NA,EC = 0.048 μM)是强效且选择性的CB受体部分激动剂,二者水溶性均有所提高。

相似文献

2
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
ACS Chem Neurosci. 2021 Nov 3;12(21):4020-4036. doi: 10.1021/acschemneuro.1c00348. Epub 2021 Oct 22.
3
Strategies to develop selective CB receptor agonists from indole carboxamide synthetic cannabinoids.
Eur J Med Chem. 2019 Oct 15;180:291-309. doi: 10.1016/j.ejmech.2019.07.036. Epub 2019 Jul 11.
4
7
Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB receptor agonists.
Arch Pharm (Weinheim). 2023 Mar;356(3):e2200493. doi: 10.1002/ardp.202200493. Epub 2022 Nov 27.

引用本文的文献

1
Polar alcohol guest molecules regulate the stacking modes of 2-D MOF nanosheets.
Chem Sci. 2024 Feb 7;15(11):4106-4113. doi: 10.1039/d3sc06844g. eCollection 2024 Mar 13.
2
Divergent access to 5,6,7-perifused cycles.
Nat Commun. 2023 Aug 24;14(1):5148. doi: 10.1038/s41467-023-40801-0.
3
Rational drug design of CB2 receptor ligands: from 2012 to 2021.
RSC Adv. 2022 Dec 8;12(54):35242-35259. doi: 10.1039/d2ra05661e. eCollection 2022 Dec 6.
4
Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells.
RSC Med Chem. 2021 Aug 23;12(11):1910-1925. doi: 10.1039/d1md00065a. eCollection 2021 Nov 17.
5
Novel approaches and current challenges with targeting the endocannabinoid system.
Expert Opin Drug Discov. 2020 Aug;15(8):917-930. doi: 10.1080/17460441.2020.1752178. Epub 2020 Apr 27.

本文引用的文献

1
Strategies to develop selective CB receptor agonists from indole carboxamide synthetic cannabinoids.
Eur J Med Chem. 2019 Oct 15;180:291-309. doi: 10.1016/j.ejmech.2019.07.036. Epub 2019 Jul 11.
2
Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor.
J Med Chem. 2018 May 24;61(10):4370-4385. doi: 10.1021/acs.jmedchem.7b01820. Epub 2018 May 10.
3
Ajulemic acid: potential treatment for chronic inflammation.
Pharmacol Res Perspect. 2018 Apr;6(2):e00394. doi: 10.1002/prp2.394.
4
Itch in dermatomyositis: the role of increased skin interleukin-31.
Br J Dermatol. 2018 Sep;179(3):669-678. doi: 10.1111/bjd.16498. Epub 2018 Jun 21.
5
Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.
Front Immunol. 2017 Nov 10;8:1487. doi: 10.3389/fimmu.2017.01487. eCollection 2017.
6
7
8
Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.
Anal Biochem. 2016 Apr 1;498:8-28. doi: 10.1016/j.ab.2015.12.019. Epub 2016 Jan 7.
9
Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
Eur J Pharm Sci. 2015 Jan 25;67:85-96. doi: 10.1016/j.ejps.2014.11.003. Epub 2014 Nov 14.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验